Abstract:Hepatocyte-like cells (HLCs) derived from human induced pluripotent stem cells (hiPSCs), with their potential capacity to phenotypically model the influence of genetic variation, could be a useful in vitro hepaticmodel to aidmechanistic understanding of drug-induced liver injury in humans. However, the generation of HLCs with a functionally similar phenotype to the gold standard in vitro model of human primary hepatocytes remain elusive. Furthermore there is a significant variation reported for the differentiation propensities of various hiPSC lines towards the hepatic lineage, although the precise reasons are unclear. Recent reports have highlighted the potential importance of the parental cell used for cellular reprogramming, as hiPSCs may retain an epigenetic memory of their original cell type, with a propensity to differentiate back to its lineage of origin. Therefore, we hypothesize that HLCs generated from hepatocyte-derived hiPSCs may exhibit an improved functional phenotype compared to non-hepatocyte-derived hiPSCs. To control for genotypic differences, variations in the reprogramming techniques, and differences in the hepatic differentiation protocols, we derived hiPSC lines from primary hepatocytes and dermal fibroblasts from the same donors using a non-integrative reprogrammingmethod, and generated HLCs using the same differentiation protocol. The hepatocyte-derived hiPSC (H-hiPSC) lines and dermal fibroblast-derived hiPSC (F-hiPSC) lines successfully generated from the same donors were positive for the pluripotency markers OCT4, SOX2, NANOG, TRA-1-60 and SSEA4, and could spontaneously differentiate into cells of all three germ layers. HLCs were differentiated from all the hiPSC lines and were shown to be positive for the endodermal lineage-specific markers of SOX17, HNF4A and ALB. The HLCs were generated using hiPSCs at low passage numbers (<10) to avoid any loss of epigenetic memory which could arise as a result of continued passage in culture. Separate cultures of HLCs generated from the H-hiPSC and F-hiPSC lines were compared against the donors' primary hepatocytes using real-time PCR for expression of liver-related genes, immunoblotting and assays of key hepatic metabolic function. Our resource of having H-hiPSC and F-hiPSC lines to generate HLCs, with the availability of primary hepatocytes from the same donor as the most appropriate comparator, allows for a definitive assessment of the role of epigenetic memory of the cell origin used for cellular reprogramming, in determining the propensity for hepatic differentiation.

RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers

Human Hepatic Progenitor Cells Express Hematopoietic Cell Markers Cd45 And Cd109

Efficient Generation of Functional Hepatocyte-Like Cells from Mouse Liver Progenitor Cells Via Indirect Co-Culture with Immortalized Human Hepatic Stellate Cells.

Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells

Comparative transcriptomic and phenotypic analysis of induced pluripotent stem cell hepatocyte-like cells and primary human hepatocytes

Analysis of differentially expressed genes among human hair follicle–derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes

Single Cell, Single Nucleus and Spatial RNA Sequencing of the Human Liver Identifies Hepatic Stellate Cell and Cholangiocyte Heterogeneity

A human liver cell atlas reveals heterogeneity and epithelial progenitors

Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing

A Human Liver Cell Atlas: Revealing Cell Type Heterogeneity and Adult Liver Progenitors by Single-Cell RNA-sequencing

Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles

Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver

Clonal Expansion of Hepatic Progenitor Cells and Differentiation into Hepatocyte‐like Cells

643 Mutations in Cel and Hras1 Are Associated with Obesity-Associated Hepatocellular Carcinoma

Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury

Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells

Single-cell Transcriptomics of Hepatic Stellate Cells Uncover Crucial Pathways and Key Regulators Involved in Non-Alcoholic Steatohepatitis

Repopulation Efficiencies of Adult Hepatocytes, Fetal Liver Progenitor Cells, and Embryonic Stem Cell-Derived Hepatic Cells in Albumin-Promoter-enhancer Urokinase-Type Plasminogen Activator Mice.

Patient-derived HCC cells recapitulating the transcriptomic landscape of primary HCV-related liver cancer

Hepatic Progenitor Cell Represents a Transitioning Cell Population Between Liver Epithelium and Stroma

Proliferation and Differentiation Potential of Mouse Adult Hepatic Progenitor Cells Cultured in Vitro